Abstract
Purpose of Review
The purpose of this manuscript is to review the most recent literature pertinent to the presence of vasculitis in patients with systemic lupus erythematosus (SLE), including previously published landmark articles and studies and to update the different clinical and diagnostic aspects of vasculitic manifestations in patients with this important autoimmune disorder. As a multisystem autoimmune disease, systemic lupus may attack practically any organ system in the human body. Even though vasculitis is not the most common presentation or pathogenic mechanism of disease, it frequently causes significant morbidity and mortality in patients with SLE. The most common manifestation of lupus vasculitis is cutaneous involvement; visceral involvement is less common but causes severe disease; it may occur in different areas including central nervous system, peripheral nervous system, gastrointestinal system, kidneys, lungs and even retina.
Recent Findings
Recent findings regarding the pathogenesis of lupus CNS and peripheral nerve disease, and vascular injury in lupus nephritis are reviewed as well.
Summary
Vasculitis is an uncommon but serious manifestation of SLE; it may involve different organ systems and present in a wide variety of clinical syndromes, and thus the importance of its recognition and early diagnosis by physicians who deal with this disease, in order to start prompt and aggressive therapy when indicated.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Lim SS, Drenkard C. Epidemiology of lupus: an update. Curr Opin Rheumatol. 2015;27(5):427–32.
Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep. 2014;16:440.
Ramos-Casals M, Nardi N, Lagrutta M, Brito-Zerón P, Bové A, Delgado G, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006;85(2):95–104.
Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D. Vasculitis in systemic lupus. Lupus. 1997;6(3):235–42.
Grönhagen CM, Gunnarsson I, Svenungsson E, Nyberg F. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus. Lupus. 2010;19(10):1187–94.
Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V. Connective tissue disorder-associated vasculitis. Curr Rheumatol Rep. 2016;18(6):31.
Fukuda MV, Lo SC, de Almeida CS, Shinjo SK. Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus. Clin Rheumatol. 2009;28(3):301–4.
García-Carrasco M, Ramos-Casals M, Cervera R, Trejo O, Yagüe J, Sisó A, et al. Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. Semin Arthritis Rheum. 2001;30(5):366–73.
• Micheletti RG. Cutaneous vasculitis in rheumatologic disease: Current concepts of skin and systemic manifestations. Clin Dermatol. 2018;36(4):561–6 Nice summary and general review of cutaneous vasculitis in different rheumatologic disorders, concise but complete, good article for reference.
Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2018;70(2):171–84.
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992;10(5):527–39.
Calamia KT, Balabanova M. Vasculitis in systemic lupus erythematosus. Clin Dermatol. 2004;22:148–56.
Jafri K, Patterson SL, Lanata C. Central nervous system manifestations of systemic lupus erythematosus. Rheum Dis Clin N Am. 2017;43(4):531–45.
Kleinig TJ, Koszyca B, Blumbergs PC, Thompson P. Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus. Lupus. 2009;18(6):486–90.
Rodrigues M, Galego O, Costa C, Jesus D, Carvalho P, Santiago M, et al. Central nervous system vasculitis in systemic lupus erythematosus: a case series report in a tertiary referral centre. Lupus. 2017;26(13):1440–7.
Edgell RC, Sarhan AE, Soomro J, Einertson C, Kemp J, Shirani P, et al. The role of catheter angiography in the diagnosis of central nervous system vasculitis. Interv Neurol. 2016;5(3–4):194–208.
Böckle BC, Jara D, Aichhorn K, Junker D, Berger T, Ratzinger G, et al. Cerebral large vessel vasculitis in systemic lupus erythematosus. Lupus. 2014;23(13):1417–21.
Younger DS, Coyle PK. Central nervous system vasculitis due to infection. Neurol Clin. 2019;37(2):441–63.
Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun. 2016;74:41–72.
Abdel Razek AA, Alvarez H, Bagg S, Refaat S, Castillo M. Imaging spectrum of CNS vasculitis. Radiographics. 2014;34(4):873–94.
•• Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15(MARCH):137–52 Excellent review of the complex topic of neuropsychiatric lupus; it includes clinical and diagnostic aspects and a comprehensive overview of pathogenesis and neuroimmune mechanisms of disease.
Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, et al. Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes. Stroke. 2015;46(6):1567–73.
Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol. 1995;22:662–7.
Liem MD, Gzesh DJ, Flanders AE. MRI and angiographic diagnosis of lupus cerebral vasculitis. Neuroradiology. 1996;38(2):134–6.
• Kröner P, Tolaymat O, Bowman A, Abril A, Lacy B. Gastrointestinal manifestations of rheumatological diseases. Am J Gastroenterol. 2019;114(9):1441–54 Comprehensive review of the general GI manifestations of connective tissue diseases.
Maruyama A, Nagashima T, Iwamoto M, Minota S. Clinical characteristics of lupus enteritis in Japanese patients: the large intestine-dominant type has features of intestinal pseudo-obstruction. Lupus. 2018;27(10):1661–9.
Yuan S, Ye Y, Chen D, Qiu Q, Zhan Z, Lian F, et al. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease. Semin Arthritis Rheum. 2014;43(6):759–66.
Kwok SK, Seo SH, Ju JH, Park KS, Yoon CH, Kim WU, et al. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus. 2007;16(10):803–9.
• Brewer BN, Kamen DL. Gastrointestinal and hepatic disease in systemic lupus erythematosus. Rheum Dis Clin N Am. 2018;44(1):165–75 Summarizes the main and most common gastrointestinal manifestations of lupus and provides a nice review of the topic.
Koo BS, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B. Lupus enteritis: clinical characteristics and predictive factors for recurrence. Lupus. 2015;24(6):628–32.
Liu A, Zhang W, Tian X, Zhang X, Zhang F, Zeng X. Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients. Lupus. 2009;18(12):1112–8.
Da Rocha MC, Vilar MJ, Freire EA, Santiago MB. Arterial occlusion in systemic lupus erythematosus: a good prognostic sign? Clin Rheumatol. 2005;24(6):602–5.
Burgos PI, Vilá LM, Reveille JD, Alarcón GS. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus. 2009;18(14):1303–8.
Nagai Y, Shimizu A, Suto M, Tanaka S, Yasuda M, Tago O, et al. Digital gangrene in systemic lupus erythematosus. Acta Derm Venereol. 2009;89:398–401.
Bortoluzzi A, Piga M, Silvagni E, Chessa E, Mathieu A, Govoni M. Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome. Lupus. 2019;28(4):465–74.
• Toledano P, Orueta R, Rodríguez-Pintó I, Valls-Solé J, Cervera R, Espinosa G. Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre. Autoimmun Rev. 2017;16(7):750–755. Interesting observational study evaluating peripheral nerve disease in patients with SLE. It looks into a possible correlation between peripheral neuropathy and other variables such as hematologic abnormalities and age. It also provides information about treatment response.
Jasmin R, Sockalingam S, Ramanaidu LP, Goh KJ. Clinical and electrophysiological characteristics of symmetric polyneuropathy in a cohort of systemic lupus erythematosus patients dot lupus 2015; 24(3):248–55.
Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, et al. Peripheral nervous system disease in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Rheum. 2020;72(1):67–77.
Stefurak TL, Midroni G, Bilbao JM. Vasculitic polyradiculopathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1999;66:658–61.
Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011 Oct;41(2):203–11.
• Leatherwood C, Speyer CB, Feldman CH, D’Silva K, Gómez-Puerta JA, Hoover PJ, Waikar SS, McMahon GM, Rennke HG, Costenbader KH. Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. Semin Arthritis Rheum. 2019;49(3): 396-404. This study investigates the correlation between histologic patterns in 202 renal biopsy samples of patients with lupus nephritis such as interstitial fibrosis, tubular atrophy and vascular injury, and its prognostic and clinical implications.
Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, et al. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int. 2013;83(4):715–23.
Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, et al. Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol. 2012 May;7(5):757–64.
Banfi, G, Bertani T, Boeri V, Faraggiana, T, Mazzucco G, Monga G, Sacchi G. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis, Vol XVIII, No 2 (August), 1991: pp 240–248.
Medina G, Gonzalez-Perez D, Vazquez-Juarez C, Sanchez-Uribe M, Saavedra MA, Jara LJ. Fulminant systemic vasculitis in systemic lupus erythematosus. Case report and review of the literature. Lupus. 2014;23:1426–9.
Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med. 1981 Nov;71(5):791–8.
Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med. 2018;39(4):482–93.
Andrade C, Mendonça T, Farinha F, Correia J, Marinho A, Almeida I, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus. 2016;25(1):75–8.
Wang CR, Liu MF, Weng CT, Lin WC, Li WT, Tsai HW. Systemic lupus erythematosus associated diffuse alveolar haemorrhage: a single-centre experience in Han Chinese patients. Scnad J Rheumatol. 2018;47(5):392–9.
• Kim D, Choi J, Cho SK, Choi CB, Kim TH, Jun JB, et al. Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;46(6):782–7 This is an interesting study that compares patients with diffuse alveolar hemorrhage with patients with pulmonary infiltrates without DAH and describes morbidity and prognosis.
Myers JL, Katzenstein AL. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol. 1986;85(5):552–6.
Al-Adhoubi NK, Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus. 2020 Apr;29(4):355–63.
Rojas-Serrano J, Pedroza J, Regalado J, Robledo J, Reyes E, Sifuentes-Osornio J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus. 2008;17(4):295–9.
Conigliaro P, Cesareo M, Chimenti MS, Triggianese P, Canofari C, Barbato C, et al. Take a look at the eyes in systemic lupus erythematosus: a novel point of view. Autoimmun Rev. 2019;18(3):247–54.
Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135–41.
Butendieck RR, Parikh K, Stewart M, Davidge-Pitts C, Abril A. Systemic lupus erythematosus-associated retinal vasculitis. J Rheumatol. 2012;39(5):1095–6.
Androudi S, Dastiridou A, Symeonidis C, Kump L, Praidou A, Brazitikos P, et al. Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol. 2013;32(1):7–13.
Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016;28(3):228–35.
Sais G, Vidaller A, Jucqla A. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131:1399–14022.
Lopez LR, Davis KC, Kohler PF, et al. The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine. J Allergy Clin Immunol. 1984;73:600–3.
Haeberle MT, Adams WB, Callen JP. Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. Arch Dermatol. 2012;148:887–8.
Chung L, Funke AA, Chakravarty EF, Callen JP, Fiorentino DF. Successful use of rituximab for cutaneous vasculitis. Arch Dermatol. 2006;142:1407–10.
Acknowledgements
Allison Dowdell from the section of scientific publications at Mayo Clinic Florida for her help with manuscript preparation and support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Vasculitis
Rights and permissions
About this article
Cite this article
Calle-Botero, E., Abril, A. Lupus Vasculitis. Curr Rheumatol Rep 22, 71 (2020). https://doi.org/10.1007/s11926-020-00937-0
Published:
DOI: https://doi.org/10.1007/s11926-020-00937-0